Intravenous Thyroxine for Heart-Eligible Organ Donors
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This randomized controlled trial will evaluate whether intravenous thyroxine infusion given
to brain-dead organ donors who are eligible to donate hearts for 12 hours will result in more
hearts transplanted than saline placebo